SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-007394
Filing Date
2016-09-27
Accepted
2016-09-27 07:46:42
Documents
4
Period of Report
2016-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s104220_8k.htm 8-K 29100
2 EXHIBIT 99.1 s104220_ex99-1.htm EX-99.1 70009
3 GRAPHIC tlogo1.jpg GRAPHIC 10539
4 GRAPHIC tlogo2.jpg GRAPHIC 7034
  Complete submission text file 0001615774-16-007394.txt   124970
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 161903349
SIC: 2834 Pharmaceutical Preparations